These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8729880)

  • 1. Model building of antibody combining sites.
    Bajorath J; Novotny J
    Ther Immunol; 1995 Apr; 2(2):95-103. PubMed ID: 8729880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-combining sites: prediction and design.
    Gregory DS; Staunton D; Martin AC; Cheetham JC; Pedersen J; Rees AR
    Biochem Soc Symp; 1990; 57():147-55. PubMed ID: 2099739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?
    Decanniere K; Muyldermans S; Wyns L
    J Mol Biol; 2000 Jun; 300(1):83-91. PubMed ID: 10864500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of antibody hypervariable loops reproduced by a conformational search algorithm.
    Bruccoleri RE; Haber E; Novotný J
    Nature; 1988 Oct; 335(6190):564-8. PubMed ID: 3419534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
    Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
    Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of an antigen-binding fragment bound to single-stranded DNA.
    Tanner JJ; Komissarov AA; Deutscher SL
    J Mol Biol; 2001 Dec; 314(4):807-22. PubMed ID: 11733999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
    Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
    Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody modeling: implications for engineering and design.
    Morea V; Lesk AM; Tramontano A
    Methods; 2000 Mar; 20(3):267-79. PubMed ID: 10694450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulations of a G protein-coupled receptor homology model predict dynamic features and a ligand binding site.
    Wolf S; Böckmann M; Höweler U; Schlitter J; Gerwert K
    FEBS Lett; 2008 Oct; 582(23-24):3335-42. PubMed ID: 18775703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.
    Faelber K; Kirchhofer D; Presta L; Kelley RF; Muller YA
    J Mol Biol; 2001 Oct; 313(1):83-97. PubMed ID: 11601848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structure-based drug design].
    Ferenczy G
    Acta Pharm Hung; 1998 Jan; 68(1):21-31. PubMed ID: 9528146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification scheme.
    Lee M; Lloyd P; Zhang X; Schallhorn JM; Sugimoto K; Leach AG; Sapiro G; Houk KN
    J Org Chem; 2006 Jul; 71(14):5082-92. PubMed ID: 16808494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of correlated motion in antibody combining sites from molecular dynamics simulations.
    Viswanathan M; Linthicum DS; Subramaniam S
    Methods; 2000 Mar; 20(3):362-71. PubMed ID: 10694457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure determinations of human and chimaeric antibodies by solution scattering and constrained molecular modelling.
    Perkins SJ; Bonner A
    Biochem Soc Trans; 2008 Feb; 36(Pt 1):37-42. PubMed ID: 18208381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.